Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia
Journal of Thrombosis and Haemostasis · 2025
DOI: 10.1016/j.jtha.2024.12.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025. Verfasst von Sooho S Myoung und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, The Ohio State University College of Medicine, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Complement Activation, Thrombocytopenia, Heparin, Platelet Factor 4. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
BACKGROUND: Immunoglobulin G antibodies (Abs) to platelet factor 4 (PF4) complexed to heparin (PF4/H) commonly occur after H exposure but cause life-threatening complications of H-induced thrombocytopenia (HIT) in only a few patients. Presently, only platelet activation assays reliably distinguish anti-PF4/H Abs that cause disease (HIT Abs) from those likely to be asymptomatic (AAbs). OBJECTIVES: Recent studies indicate that complement activation is an important serologic property of HIT Abs and is essential for IgG Fc receptor IIA-mediated cellular activation. As platelet activation by HIT Abs also relies on IgG Fc receptor IIA activation, we correlated the complement- and platelet-activating properties of anti-PF4/H Abs in a clinically annotated patient cohort. METHODS: Clinical and laboratory features of patients with HIT (n = 8) and AAbs+ (n = 14) were correlated with properties of complement, platelet, and monocyte/neutrophil activation. RESULTS: Expected clinical and laboratory differences were seen between HIT and AAb+ patients, with HIT patients having lower mean platelet counts, greater percentage drop in platelet counts, higher 4T and HIT expert probability scores, higher anti-PF4 polyclonal and immunoglobulin G Ab levels, and serotonin release assay positivity. Ex vivo assays revealed significant differences in complement activation by HIT vs AAb+ patients, with the extent of complement activation closely correlated with percent serotonin release by anti-PF4/H Abs and matrix metalloproteinase-9 and interleukin-8 release in whole blood. CONCLUSION: These findings suggest that complement activation strongly correlates with cellular activation endpoints, including platelet and monocyte/neutrophil activation, and if confirmed in a larger prospective study, may serve as a "functional" biomarker for pathogenic HIT Abs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Scientist Training Program, The Ohio State University College of Medicine, Columbus, Ohio, USA.
- Division of Hematology, Duke University Medical Center, Durham, North Carolina, USA.
- Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pathology and Laboratory Medicine, Perelman-University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
- Division of Hematology, Duke University Medical Center, Durham, North Carolina, USA. Electronic address: sanjay.khandelwal@duke.edu.
- Division of Hematology, Duke University Medical Center, Durham, North Carolina, USA. Electronic address: arepa001@mc.duke.edu.
Förderung
- NHLBI NIH HHS
- National Institutes of Health
- National Heart, Lung, and Blood Institute
Zitieren
APA
Myoung, S. S., Francis, S. J., Chen, J., Lee, G., Rauova, L., Poncz, M., Cines, D. B., Kuchibhatla, M., Khandelwal, S., & Arepally, G. M. (2025). Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2024.12.015
Vancouver
Myoung SS, Francis SJ, Chen J, Lee G, Rauova L, Poncz M, et al. Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia. Journal of Thrombosis and Haemostasis. 2025. doi:10.1016/j.jtha.2024.12.015
BibTeX
@article{Myoung2025,
author = {Myoung, Sooho S and Francis, Samuel J and Chen, Jonah and Lee, Grace and Rauova, Lubica and Poncz, Mortimer and Cines, Douglas B and Kuchibhatla, Maragatha and Khandelwal, Sanjay and Arepally, Gowthami M},
title = {Complement activation as a biomarker for platelet-activating antibodies in heparin-induced thrombocytopenia},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
doi = {10.1016/j.jtha.2024.12.015}
}
EUVIMED